TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 8 | 31 | -15 | -7 | 54 | 14 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 100 | 67 | |||
| S | %ret | 1 | 1 | 1 | 1 | -5 | -2 | -18 | 12 | -31 | -7 |
| S | %wins | 0 | 100 | 100 | 100 | 0 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/22 16:19 | 8/15/22 | CINC | Cincor Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Partners Sas | I0 | T | P | 4,000 | 30.00 | 0 | 133 | 3 | 4,221 | I | |||||||||||||||
1/13/22 16:36 | 1/11/22 | CINC | Cincor Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Partners Sas | I0 | T | P.d | 3,520 | 16.00 | 0 | 220 | 6 | 4,088 | I | |||||||||||||||
1/22/15 14:02 | 10/29/14 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Partners Sas | I0 | T | S | -200 | 20.00 | 2 | -10 | 0 | 2,095 | D | 84 | 39 | 36 | 14 | 0 | 0 | 1 | -5 | -2 | -18 | 12 | -31 | |||
2/20/14 14:59 | 2/18/14 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Partners Sas | I0 | T | P.d | 3,000 | 13.00 | 7 | 231 | 12 | 2,105 | D | 2 | 0 | 8 | 31 | -15 | -7 | 54 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |